AU2002356097A1 - Hydrazinopeptoids and their uses for treating cancers - Google Patents

Hydrazinopeptoids and their uses for treating cancers

Info

Publication number
AU2002356097A1
AU2002356097A1 AU2002356097A AU2002356097A AU2002356097A1 AU 2002356097 A1 AU2002356097 A1 AU 2002356097A1 AU 2002356097 A AU2002356097 A AU 2002356097A AU 2002356097 A AU2002356097 A AU 2002356097A AU 2002356097 A1 AU2002356097 A1 AU 2002356097A1
Authority
AU
Australia
Prior art keywords
hydrazinopeptoids
treating cancers
cancers
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002356097A
Inventor
Sandrine Aubin
Yannick Bonnemains
Karine Bouget
Michele Floc'h
Philippe Le Grel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2002356097A1 publication Critical patent/AU2002356097A1/en
Abandoned legal-status Critical Current

Links

AU2002356097A 2001-08-27 2002-08-27 Hydrazinopeptoids and their uses for treating cancers Abandoned AU2002356097A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR01/11120 2001-08-27

Publications (1)

Publication Number Publication Date
AU2002356097A1 true AU2002356097A1 (en) 2003-03-10

Family

ID=

Similar Documents

Publication Publication Date Title
IL251270A0 (en) Cancer treatment
EG24356A (en) Antitumor compounds and methods
AU2003230750A1 (en) Compositions and methods for treating cancer
EP1247815A3 (en) Modified oligonucleotides and uses thereof
EP1241577A3 (en) Methods and arrangements for improved parity-stripe processing
AU2003225535A1 (en) Methods and compositions for treating cancer
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2002359694A1 (en) Compounds and methods
AU2002308642A1 (en) Methods for treating cancer
AU2001253836A1 (en) Method of treating cancer
AU2002335667A1 (en) Modified reoviral therapy
AU2002337943A1 (en) Novel compositions and methods for cancer
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer
AU2001257325A1 (en) Cancer treatment
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2002305138A1 (en) Methods and materials for cancer treatment
AU2001100347A4 (en) IFCS firewatch
AU2001258675A1 (en) Treating infections
AU2002356097A1 (en) Hydrazinopeptoids and their uses for treating cancers
AU2002360454A1 (en) Methods and compositions for treating cancer
AU2001289127A1 (en) Tumor treatment
AU2002351382A1 (en) Combination cancer therapy
AU2001257168A1 (en) Cancer treatment
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease
AU4598100A (en) Treating cancer